Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q2 2025 (June 30)5holders −1
2new positions
3sold out
1famous investor
$1.31avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 1 from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Graypoint LLC ($1.1M), Vestcor Inc ($102K) and Citadel Advisors ($30K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q2 2025)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $42K |
| Exits | 3 | $25K |
All 13F filers, Q1 2025 → Q2 2025: 32,923 shares bought and 21,512 shares sold, net +11,411 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Graypoint LLC | — | No change | 827,590 | $1.1M |
| Vestcor Inc | — | No change | 70,832 | $102K |
| Citadel Advisors | — | New | 23,540 | $30K |
| B & T Capital Management DBA Alpha Capital Management | — | No change | 22,222 | $29K |
| Toronto Dominion Bank | — | New | 9,383 | $12K |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.